2-208124445-G-C
Variant names: 
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_006891.4(CRYGD):c.9+20C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00561 in 1,582,832 control chromosomes in the GnomAD database, including 441 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
 Genomes: 𝑓 0.029   (  215   hom.,  cov: 33) 
 Exomes 𝑓:  0.0031   (  226   hom.  ) 
Consequence
 CRYGD
NM_006891.4 intron
NM_006891.4 intron
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  -1.69  
Publications
1 publications found 
Genes affected
 CRYGD  (HGNC:2411):  (crystallin gamma D) Crystallins are separated into two classes: taxon-specific, or enzyme, and ubiquitous. The latter class constitutes the major proteins of vertebrate eye lens and maintains the transparency and refractive index of the lens. Since lens central fiber cells lose their nuclei during development, these crystallins are made and then retained throughout life, making them extremely stable proteins. Mammalian lens crystallins are divided into alpha, beta, and gamma families; beta and gamma crystallins are also considered as a superfamily. Alpha and beta families are further divided into acidic and basic groups. Seven protein regions exist in crystallins: four homologous motifs, a connecting peptide, and N- and C-terminal extensions. Gamma-crystallins are a homogeneous group of highly symmetrical, monomeric proteins typically lacking connecting peptides and terminal extensions. They are differentially regulated after early development. Four gamma-crystallin genes (gamma-A through gamma-D) and three pseudogenes (gamma-E, gamma-F, gamma-G) are tandemly organized in a genomic segment as a gene cluster. Whether due to aging or mutations in specific genes, gamma-crystallins have been involved in cataract formation. [provided by RefSeq, Jul 2008] 
CRYGD Gene-Disease associations (from GenCC):
- cataract 4 multiple typesInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
- cataract - microcornea syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- cerulean cataractInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- coralliform cataractInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- early-onset lamellar cataractInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- early-onset nuclear cataractInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- pulverulent cataractInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88). 
BP6
Variant 2-208124445-G-C is Benign according to our data. Variant chr2-208124445-G-C is described in ClinVar as Benign. ClinVar VariationId is 1261000.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. 
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0986  is higher than 0.05. 
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| CRYGD | NM_006891.4 | c.9+20C>G | intron_variant | Intron 1 of 2 | ENST00000264376.5 | NP_008822.2 | ||
| LOC100507443 | NR_038437.1 | n.97+5220G>C | intron_variant | Intron 1 of 2 | 
Ensembl
Frequencies
GnomAD3 genomes  0.0291  AC: 4425AN: 152176Hom.:  214  Cov.: 33 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
4425
AN: 
152176
Hom.: 
Cov.: 
33
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.00713  AC: 1355AN: 190104 AF XY:  0.00539   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
1355
AN: 
190104
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.00310  AC: 4434AN: 1430538Hom.:  226  Cov.: 35 AF XY:  0.00272  AC XY: 1924AN XY: 708596 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
4434
AN: 
1430538
Hom.: 
Cov.: 
35
 AF XY: 
AC XY: 
1924
AN XY: 
708596
show subpopulations 
African (AFR) 
 AF: 
AC: 
3574
AN: 
33146
American (AMR) 
 AF: 
AC: 
203
AN: 
38720
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
25404
East Asian (EAS) 
 AF: 
AC: 
2
AN: 
38496
South Asian (SAS) 
 AF: 
AC: 
12
AN: 
82160
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
50220
Middle Eastern (MID) 
 AF: 
AC: 
29
AN: 
5636
European-Non Finnish (NFE) 
 AF: 
AC: 
221
AN: 
1097458
Other (OTH) 
 AF: 
AC: 
393
AN: 
59298
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.477 
Heterozygous variant carriers
 0 
 272 
 544 
 817 
 1089 
 1361 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
 0 
 114 
 228 
 342 
 456 
 570 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  0.0292  AC: 4444AN: 152294Hom.:  215  Cov.: 33 AF XY:  0.0286  AC XY: 2132AN XY: 74484 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
4444
AN: 
152294
Hom.: 
Cov.: 
33
 AF XY: 
AC XY: 
2132
AN XY: 
74484
show subpopulations 
African (AFR) 
 AF: 
AC: 
4203
AN: 
41552
American (AMR) 
 AF: 
AC: 
182
AN: 
15304
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
3470
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
5180
South Asian (SAS) 
 AF: 
AC: 
1
AN: 
4832
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
10624
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
28
AN: 
68012
Other (OTH) 
 AF: 
AC: 
30
AN: 
2116
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.503 
Heterozygous variant carriers
 0 
 202 
 404 
 607 
 809 
 1011 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 46 
 92 
 138 
 184 
 230 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
ClinVar
Significance: Benign 
Submissions summary: Benign:3 
Revision: criteria provided, multiple submitters, no conflicts
LINK: link 
Submissions by phenotype
not provided    Benign:2 
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Sep 18, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Aculeiform cataract    Benign:1 
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.